Affordable Access

deepdyve-link
Publisher Website

Immunosuppressive strategies in lung transplantation

Authors
  • Chung, Paul A.
  • Dilling, Daniel F.
Type
Published Article
Journal
Annals of Translational Medicine
Publisher
AME Publishing Company
Publication Date
Mar 01, 2020
Volume
8
Issue
6
Identifiers
DOI: 10.21037/atm.2019.12.117
PMID: 32355853
PMCID: PMC7186623
Source
PubMed Central
Keywords
License
Unknown

Abstract

Lung transplantation is a viable option for those with end-stage lung disease which is evidenced by the continued increase in the number of lung transplantations worldwide. However, patients and clinicians are constantly faced with acute and chronic rejection, infectious complications, drug toxicities, and malignancies throughout the lifetime of the lung transplant recipient. Conventional maintenance immunosuppression therapy consisting of a calcineurin inhibitor (CNI), anti-metabolite, and corticosteroids have become the standard regimen but newer agents and modalities continue to be developed. Here we will review induction agents, maintenance immunosuppressives, adjunctive therapies and other strategies to improve long-term outcomes.

Report this publication

Statistics

Seen <100 times